FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064702 [Registered on: 22/03/2024] Trial Registered Prospectively
Last Modified On: 21/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Assessment of risk of osteoporotic fractures based on fracture risk assessment tool 
Scientific Title of Study   Assessment of risk of osteoporotic fractures based on fracture risk assessment tool: A cross-sectional study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ishank Singh 
Designation  Junior resident 
Affiliation  Rohilkhand medical college and hospital 
Address  Department of orthopaedics, Rohilkhand medical college and hospital, pilibhit by-pass road,pawan vihar, Bareilly

Bareilly
UTTAR PRADESH
243006
India 
Phone  7905147415  
Fax    
Email  ishanksingh1712@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Madan Mohan Nagar 
Designation  Professor 
Affiliation  Rohilkhand medical college and hospital 
Address  HOD chamber,Department of orthopaedics, Rohilkhand medical college and hospital, pilibhit by-pass road,pawan vihar, Bareilly

Bareilly
UTTAR PRADESH
243006
India 
Phone  9837147854  
Fax    
Email  ahanagar@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Ishank Singh 
Designation  Junior resident 
Affiliation  Rohilkhand medical college and hospital 
Address  Department of orthopaedics, Rohilkhand medical college and hospital, pilibhit by-pass road,pawan vihar, Bareilly

Bareilly
UTTAR PRADESH
243006
India 
Phone  7905147415  
Fax    
Email  ishanksingh1712@gmail.com  
 
Source of Monetary or Material Support  
Department of orthopaedics,Rohilkhand medical college and hospital, pilibhit by-pass road, pawan vihar, Bareilly, Uttar Pradesh  
 
Primary Sponsor  
Name  Rohilkhand medical college and hospital  
Address  Rohilkhand medical college and hospital, pilibhit by-pass road, pawan vihar, Bareilly  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ishank Singh  Rohilkhand medical college and hospital  Department of orthopaedics,Rohilkhand medical college and hospital, pilibhit by-pass road, pawan vihar
Bareilly
UTTAR PRADESH 
7905147415

ishanksingh1712@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee,RMCH, Bareilly  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M80-M85||Disorders of bone density and structure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Age between 40 to 90 years.
Both genders included
Primary osteoporosis.
Patient willing for study. 
 
ExclusionCriteria 
Details  Patients on anti-resorptive treatment.
Bone metastasis and other secondary osteoporosis patients. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine risk of osteoporotic fractures based on fracture risk assessment tool with and without BMD.   1 year 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the values & risk of osteoporotic fractures using fracture risk assessment tool with & without bone mineral density.  1 year 
 
Target Sample Size   Total Sample Size="170"
Sample Size from India="170" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Osteoporosis is a systemic skeletal disorder which is nicknamed "silent thief" due to the asymptomatic nature of the disorder until it causes an osteoporotic facture 7. Osteoporotic fractures are one of the major causes of death in elderly men and women across the world 7. Fragility fractures associated with osteoporosis are common and cause significant costs, morbidity, and mortality 7. Neck of femur fractures are the major cause of morbidity and mortality, although reliable epidemiological data are lacking hospital data suggest that neck of femur fractures are common in India Calcium and vitamin D nutrition plays an important role in determining bone health. Vitamin D Deficiency (VDD) in adults can precipitate or exacerbate osteopenia and osteoporosis and increase the risk of fractures, but question is how to detect and treat such cases and how to predict cases, for treatment or preventive measures, with good and cost-effective manner, especially in the rural population of country like INDIA where patients cannot afford “DEXA SCANS” for economic and availability reasons. The WHO introduced Fracture Risk Assessment Tool (FRAX) in 2008 for use of estimating the 10-year probability of osteoporotic fractures (neck of femur, spine, distal end radius, forearm) in untreated patients with osteopenia. FRAX calculates fracture probability of individuals from age, body mass index and risk factors comprising prior fragility fracture, parental history of neck of femur fracture, current tobacco smoking, Overuse of long term oral glucocorticoids, rheumatoid arthritis, other causes of secondary osteoporosis, and alcohol consumption with information on BMD 7. Therapeutic interventions are recommended if the 10-year risk of fractures is more than 20% for major osteoporotic fractures (MOF) and more than 3% for neck of femur fractures. The aim of my study is to determine if FRAX calculations with BMD and without BMD would produce comparable predictions for the 10 year probability of osteoporotic fractures. Being a silent disease osteoporosis is affecting millions of population and leading to osteoporotic fractures. As there are very few studies done in the western Uttar Pradesh region, this study will be in novel cause and will be beneficial study in prevention and treatment of population in and around this region.  
Close